4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-005838
EVP and Chief Medical Officer sold 1,657 shares at $66.30 ($109,859)
From the SEC's structured data for this filing
Trades in this filing
Bedrosian Camille L · EVP and Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-30 | Sale : show line 1 in the form | −1,657 | $66.30 | $109,859 | 36,759 | D |
| Open-market sales · 1,657 sh · avg $66.30 · $109,859 | ||||||
Loading xslF345X03/doc4.xml…